Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

Todd Neale

October 02, 2025

News Daily News

HFSA Cancels Annual Meeting Due to Looming Hurricane

L.A. McKeown

September 26, 2024

News Daily News

ACC Updates Pathway for Hospitalized HF Patients

Todd Neale

August 12, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Daily News

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

Shelley Wood

August 04, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer

Michael O'Riordan

May 10, 2017

Advertisement

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

HFSA Cancels Annual Meeting Due to Looming Hurricane

ACC Updates Pathway for Hospitalized HF Patients

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

Vast Majority of HFrEF Patients Eligible for Vericiguat

Top Heart Failure News of 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content